Regulus Therapeutics to Present at the 2020 Wells Fargo Virtual Healthcare ConferencePRNewsWire • 09/03/20
Regulus Therapeutics Announces Restructuring of Sanofi and Oxford Loan AgreementsPRNewsWire • 08/31/20
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent UpdatesPRNewsWire • 08/13/20
Regulus (RGLS) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 08/06/20
Regulus Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferencePRNewsWire • 08/06/20
Regulus Therapeutics Announces FDA Orphan Drug Designation of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)PRNewsWire • 07/29/20
Regulus Therapeutics Completes Dosing in Phase 1 Multiple Ascending Dose Study of RGLS4326 in Healthy Volunteers for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)PRNewsWire • 07/22/20
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent UpdatesPRNewsWire • 05/14/20
Regulus (RGLS) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 05/07/20
Regulus (RGLS) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks Investment Research • 03/09/20
Will Regulus (RGLS) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 08/01/19
Will Regulus (RGLS) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 05/02/19